Houston Methodist Doctor Who Resigned Following Suspension Over Controversial Covid-19 Tweets

Houston Methodist Doctor Who Resigned Following Suspension Over Controversial Covid-19 Tweets

Nov. 17, 2021

Texas Doctor Suspended, Banned From Giving Ivermectin To Critically Ill Covid Patient.

Believes Hospital Is 'Targeting Her'

"I have treated more than 2000 COVID-19 patients, including many with comorbidities, and none of these patients have required hospitalization," said Dr. Mary Bowden, who was suspended from a Texas hospital after promoting Ivermectin as a COVID treatment.

The local doctor who was suspended by Houston Methodist after they said she was spreading misinformation about COVID-19 treatments has resigned Tuesday.

Doctor Mary Bowden is an ear, nose and throat specialist. She runs her own private practice BreatheMD, but just recently joined the staff at Houston Methodist.

Bowden's resignation comes days after Houston Methodist suspended the doctor's hospital privileges and accused her of "using her social media accounts to express her personal and political opinions about the COVID-19 vaccine and treatments."

Dr. Mary Bowden, a private-practice ear, nose, and throat doctor trained at the Medical College of Georgia, was temporarily suspended from Houston Methodist earlier this month after repeatedly speaking out about the benefits of ivermectin for COVID patients. Bowden has said that she has treated 2,000 people for COVID-19, in some cases using the drug, and that none of her patients have been hospitalized.

"Ivermectin might not be as deadly as everyone said it was," she tweeted November 10. "Speak up!"

Bowden has also criticized COVID vaccine mandates and announced in a recent post that she is "shifting my practice focus to treating the unvaccinated."

Dr. Bowden, who was informed about her suspension by a reporter for the Houston Chronicle, resigned last Monday. In a letter explaining the move, she said that Houston Methodist's accusations that she spread "dangerous misinformation" are "false and defamatory."

"During the past two years, I have worked hard to provide early treatment for victims of COVID-19. My efforts have been successful. I have treated more than 2,000 COVID-19 patients, including many with comorbidities, and none of these patients have required hospitalization. This is a testament to the success of my treatment methods," she wrote.

"I do not spread misinformation, and my opinions are supported by science. There is substantial evidence for the efficacy of ivermectin in treating COVID-19 and no evidence for serious or fatal side effects associated with the doses used to treat for COVID-19."

She added that many of her patients have used the drug with other therapies as part of successful recovery regimens. "I believe that if more physicians had focused on early treatment, many COVID-related deaths and hospitalizations could have been prevented," she said.

The doctor said she feels like the hospital is targeting her.

"I do not appreciate the way Methodist handled this. I'm simply trying to help my patients," Bowden said.

She added that all of the newfound attention puts her medical license at risk. She says an online group is encouraging people across the country to report her to the medical board.

"On the one hand, it's very stressful. On the other hand, I have been overwhelmed by the support that I have received," Bowden said. "Prior to COVID, I had absolutely no interest in politics. I have been sort of been forced into an area of politics, but prior to COVID, I had zero interest in politics."

At a press conference on Wednesday, Bowden called for Houston Methodist to release all COVID-19 data, including any breakthrough cases among those vaccinated.

"I want them to show all of their data. Let's have some data transparency," she said.

Steven Mitby, Bowden's attorney, said she has plenty of options to consider moving forward, but would not say if suing Houston Methodist is on the list.

https://www.lifesitenews.com/news/texas-doctor-suspended-prohibited-from-prescribing-ivermectin-to-covid-patient/